Green Alpha Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $257K | Sell |
207,023
-9,771
| -5% | -$12.1K | 0.25% | 88 |
|
|
2025
Q1 | $256K | Buy |
216,794
+114,373
| +112% | +$135K | 0.27% | 89 |
|
|
2024
Q4 | $187K | Buy |
102,421
+38,208
| +60% | +$69.9K | 0.15% | 129 |
|
|
2024
Q3 | $109K | Buy |
64,213
+30,117
| +88% | +$51.2K | 0.09% | 134 |
|
|
2024
Q2 | $46.7K | Sell |
34,096
-15,851
| -32% | -$21.7K | 0.04% | 137 |
|
|
2024
Q1 | $187K | Buy |
49,947
+8,512
| +21% | +$31.9K | 0.14% | 132 |
|
|
2023
Q4 | $406K | Sell |
41,435
-32,811
| -44% | -$322K | 0.29% | 118 |
|
|
2023
Q3 | $620K | Sell |
74,246
-36,865
| -33% | -$308K | 0.48% | 77 |
|
|
2023
Q2 | $1.48M | Buy |
111,111
+6,216
| +6% | +$82.7K | 0.97% | 33 |
|
|
2023
Q1 | $1.21M | Buy |
104,895
+437
| +0.4% | +$5.06K | 0.85% | 46 |
|
|
2022
Q4 | $854K | Sell |
104,458
-312
| -0.3% | -$2.55K | 0.71% | 56 |
|
|
2022
Q3 | $608K | Sell |
104,770
-318,066
| -75% | -$1.85M | 0.52% | 87 |
|
|
2022
Q2 | $1.87M | Buy |
422,836
+387,032
| +1,081% | +$1.71M | 0.43% | 55 |
|
|
2022
Q1 | $326K | Buy |
35,804
+7,757
| +28% | +$70.6K | 0.22% | 124 |
|
|
2021
Q4 | $574K | Buy |
28,047
+2,818
| +11% | +$57.7K | 0.39% | 103 |
|
|
2021
Q3 | $645K | Buy |
25,229
+4,950
| +24% | +$127K | 0.45% | 108 |
|
|
2021
Q2 | $709K | Buy |
+20,279
| New | +$709K | 0.48% | 103 |
|